Literature DB >> 15371491

Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility.

Asa Andersson1, Riikka Kokkola, Judit Wefer, Helena Erlandsson-Harris, Robert A Harris.   

Abstract

Rodents typically demonstrate strain-specific susceptibilities to induced autoimmune models such as experimental arthritis and encephalomyelitis. A common feature of the local pathology of these diseases is an extensive infiltration of activated macrophages (MPhi). Different functional activation states can be induced in MPhi during innate immune activation, and it is this differential activation that might be important in susceptibility/resistance to induction or perpetuation of autoimmunity. In this study, we present an extensive, comparative analysis of the activation phenotypes of MPhi derived from autoimmune-susceptible and autoimmune-resistant rat strains to describe a cellular phenotype that defines the disease phenotype. We included investigation of receptor function, intracellular signaling pathways, cytokines, and other soluble mediators released after activation of cells using a panel of stimuli embracing many activation routes. We report that activation of MPhi from the autoimmune-susceptible strain was associated with alternative activation indicated by induction of arginase activity, a lower production of classical proinflammatory mediators, and a high production of interleukin (IL)-23, and MPhi from the autoimmune-resistant strains were associated with a higher production of proinflammatory mediators, a classical activation phenotype, and preferential induction of IL-12. These MPhi phenotypes thus reflect disparate, genetic cellular programs that define autoimmune susceptibility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371491     DOI: 10.1189/jlb.0704385

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  17 in total

Review 1.  A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Authors:  Brian Astry; Erin Harberts; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  Genetic loci modulate macrophage activity and glomerular damage in experimental glomerulonephritis.

Authors:  Jacques Behmoaras; Jennifer Smith; Zelpha D'Souza; Gurjeet Bhangal; Ratana Chawanasuntoropoj; Frederick W K Tam; Charles D Pusey; Timothy J Aitman; H Terence Cook
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

3.  Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma.

Authors:  Thomas V Johnson; Natalie D Bull; David P Hunt; Nephtali Marina; Stanislav I Tomarev; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

Review 4.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

5.  LPS and poly I:C induce chromatin modifications at a novel upstream region of the IL-23 p19 promoter.

Authors:  Stacey Garrett; Michael C Fitzgerald; Kathleen E Sullivan
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092

6.  Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period.

Authors:  Ralph Feuer; Chelsea M Ruller; Naili An; Jenna M Tabor-Godwin; Ross E Rhoades; Sonia Maciejewski; Robb R Pagarigan; Christopher T Cornell; Stephen J Crocker; William B Kiosses; Ngan Pham-Mitchell; Iain L Campbell; J Lindsay Whitton
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

7.  Regulation of IL-17A expression in mice following subacute ozone exposure.

Authors:  Jeffrey D Brand; Joel A Mathews; David I Kasahara; Alison P Wurmbrand; Stephanie A Shore
Journal:  J Immunotoxicol       Date:  2016-04-04       Impact factor: 3.000

8.  Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility.

Authors:  Jacques Behmoaras; Gurjeet Bhangal; Jennifer Smith; Kylie McDonald; Brenda Mutch; Ping Chin Lai; Jan Domin; Laurence Game; Alan Salama; Brian M Foxwell; Charles D Pusey; H Terence Cook; Timothy J Aitman
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

9.  Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.

Authors:  Roham Parsa; Pernilla Andresen; Alan Gillett; Sohel Mia; Xing-Mei Zhang; Sofia Mayans; Dan Holmberg; Robert A Harris
Journal:  Diabetes       Date:  2012-06-28       Impact factor: 9.461

10.  Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.

Authors:  Xing-Mei Zhang; Harald Lund; Sohel Mia; Roham Parsa; Robert A Harris
Journal:  Glia       Date:  2014-05       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.